Logo Image
|Podcasts|December 26, 2018

Looking Back and Ahead: AJMC®'s Editors-in-Chief Recap 2018 and Make Predictions for 2019

As 2018 draws to a close, The American Journal of Managed Care®'s co-editors-in-chief recapped their favorite papers published in 2018 and made predictions for 2019.

As 2018 draws to a close, The American Journal of Managed Care® (AJMC®)'s co-editors-in-chief, A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design at the University of Michigan, and Michael E. Chernew, PhD, director of the Healthcare Markets and Regulation Lab at Harvard Medical School, recapped their favorite AJMC® papers published in 2018, identified events from the year that are likely to impact future research in the journal, and looked ahead to 2019 with healthcare and health policy predictions.

You may need to log in to the website to access this podcast.

iTunes: http://apple.co/2eYWTss?rel=0"

TuneIn: http://bit.ly/2gv7iwj?rel=0"

Stitcher: http://bit.ly/2gCqtFg?rel=0"

Listen above or through one of these podcast services:

Financial Burden of Healthcare Utilization in Consumer-Directed Health Plans

A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery

Overall US Healthcare Spending Growth Slowed for Second Year, CMS Says

Levers to Reduce Use of Unnecessary Services: Creating Needed Headroom to Enhance Spending on Evidence-Based Care

Addressing Low-Value Care and a Better Benefit Design at the V-BID Summit

Federal Judge Strikes Down Affordable Care Act

In the Wake of ACA Ruling, the Only Thing Certain Is Uncertainty

Read more about the papers and news events mentioned:

Related to this article

View more
Daniel Kyung Min, PharmD | Image: LinkedIn
High-Intensity IV Iron Replacement for Chronic Bleeding in HHT: A Case Series
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Read more